Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients

Retina

Volumn 28, Issue 10, 2008, Pages 1427-1434

  Warren, Keith A ^a,b   Fox, Jenni E ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b Warren Retina Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NEPAFENAC; BENZENEACETAMIDE DERIVATIVE; EYE DROPS; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLACETIC ACID DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE INFLAMMATION; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; PSEUDOPHAKIA; RETINA ANGIOGRAPHY; RETINA MACULA CYSTOID EDEMA; THERAPY EFFECT; THICKNESS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; CATARACT EXTRACTION; CHRONIC DISEASE; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY; RETINA; RETINA MACULA EDEMA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; CATARACT EXTRACTION; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PHENYLACETATES; PILOT PROJECTS; PROSPECTIVE STUDIES; PSEUDOPHAKIA; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 58949090202     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31817e7ead     Document Type: Article

References (18)

1. Gulkilik G, Kocabora S, Taskapili M, et al. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol 2006;41:699-703.
2. Ursell PG, Spalton DJ, Whitcup SM, et al. Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg 1999;25:1492-1497.
3. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol 2002;17:167-180.
4. Stark WJ Jr, Maumenee AE, Fagadau W, et al. Cystoid macular edema in pseudophakia. Surv Ophthalmol 1984;28: 442-451.
5. Wright PL, Wilkinson CP, Balyeat HD, et al. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 1988;106:740-744.
6. Lindstrom R, Kim T. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac. Curr Med Res Opin 2006;22:397-404.
7. Gamache DA, Graff G, Brady MT, et al. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation. I. Assessment of anti-inflammatory efficacy. Inflammation 2000;24: 357-370.
8. Ke TL, Graff G, Spellman JM, et al. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation. II. In vitro bioactivation and permeation of external ocular barriers. Inflammation 2000; 24:371-384.
9. Kapin MA, Yanni JM, Brady MT, et al. Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac. Inflammation 2003;27:281-291.
10. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991;112:514-519.
11. Peterson M, Yoshizumi MO, Hepler R, et al. Topical indo-methacin in the treatment of chronic cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 1992;230:401- 405.
12. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg 2003;29:2378 -2384.
13. Warren K, Fox JE. NSAID as an alternate treatment modality for CME in the steroid-responsive patient. Paper presented at: The Retina Society; Boston, MA; September 27-30, 2007.
14. Akduman L, Clever JA, Feman S. Nepafenac used for the treatment chronic pseudophakic cystoid macular edema. Paper presented at: The Retina Society; Boston, MA; September 27-30, 2007.
15. Hariprasad SM, Mieler WF. Treatment of acute pseudophakic, chronic pseudophakic, and recalcitrant uveitic cystoid macular edema with nepafenac 0.1% (Nevanac). Paper presented at: The Retina Society; Boston, MA; September 27-30, 2007.
16. Gross JG. Xibrom (bromfenac) reduces cystoid macular edema associated with vein occlusions, macular epiretinal membrane, diabetic retinopathy and age-related macular degeneration. Paper presented at: The Retina Society; Boston, MA; September 27-30, 2007.
17. Hariprasad SM, Callanan D. Topical nepafenac 0.1% for treatment of chronic uveitic cystoid macular edema. Retinal Cases Brief Rep. In press.
18. Hariprasad SM, Callanan D, Gainey S, et al. Cystoid and diabetic macular edema treated with nepafenac 0.1%. J Ocul Pharmacol Ther 2007;23:585-590.